Skip to main content

Advertisement

SpringerLink
Log in

Can web 2.0 reboot clinical trials?

  • Feature
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

An Erratum to this article was published on 01 February 2010

This article has been updated

Dozens of companies are trying to leverage social networking and other software tools to accelerate trials and reduce their cost.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 3: Google founder Sergey Brin has become part of the clinical trial revolution on the web.
Figure 2: TrialX iPhone app lets patients and doctors search for clinical trials by location, indication or treatment, share it with friends or family, and call a clinical trial investigator.

Change history

  • 05 February 2010

    In the version of this article initially published, Sharib Khan was incorrectly identified as the CEO of TrialX. He is cofounder. The error has been corrected in the HTML and PDF versions of the article.

References

  1. Westing, A.F. How the Public Views Privacy and Health Research (National Academy of Sciences, Washington, DC, 2007).

    Google Scholar 

  2. Arnst, C. Health 2.0, Patients as Partners, Business Week, December 4, 2008 http://www.businessweek.com/magazine/content/08_50/b4112058194219.htm

    Google Scholar 

  3. Ramsey, S. & Scoogins, J. Practicing on the tip of an iceberg? Evidence of underpublication of registered clinical trials in oncology. Oncologist 13, 925–929 (2008).

    Article  Google Scholar 

  4. Kurzrock, R. et al. Project zero delay: a process for accelerating the activation of cancer clinical trials. J. Clin. Oncol. 27, 4433–4440 (2009).

    Article  Google Scholar 

  5. Greggio, E. & Cookson, M.R. Leucine-rich repeat kinase 2 mutations and Parkinson's disease: three questions. ASN Neuro. published online, doi: 10.1042/AN20090007 (14 April 2009).

Download references

Author information

Authors and Affiliations

  1. Malorye Allison is a freelance writer based in Acton, MA.,

    Malorye Allison

Authors
  1. Malorye Allison
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Allison, M. Can web 2.0 reboot clinical trials?. Nat Biotechnol 27, 895–902 (2009). https://doi.org/10.1038/nbt1009-895

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt1009-895

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation